BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2015 10:30:00 AM | Browse: 1121 | Download: 1499
Publication Name World Journal of Virology
Manuscript ID 18645
Country/Territory Japan
Received
2015-04-26 13:27
Peer-Review Started
2015-04-28 17:15
To Make the First Decision
2015-06-18 15:30
Return for Revision
2015-06-24 17:54
Revised
2015-06-25 09:12
Second Decision
2015-07-09 08:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-07-23 16:50
Articles in Press
2015-07-23 16:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-08-09 14:12
Publish the Manuscript Online
2015-08-13 10:30
ISSN 2220-3249 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?
Manuscript Source Invited Manuscript
All Author List Tatsuo Kanda, Shingo Nakamoto and Osamu Yokosuka
Funding Agency and Grant Number
Corresponding Author Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. kandat-cib@umin.ac.jp
Key Words Hepatitis C virus; Interleukin-28B; Interferon; Japan; Sustained virologic response
Core Tip Genome-wide association studies have revealed that interleukin-28B (IL28B) genotypes are associated with the response to interferon therapy for chronic hepatitis C. The mechanism of this association is not yet clear. Although many hepatitis C virus (HCV)-infected individuals have IL28B favorable alleles, in the near future, HCV-infected patients in Japan may be treated with interferon-free regimens, which avoid the adverse events caused by interferon plus ribavirin therapy.
Publish Date 2015-08-13 10:30
Citation Kanda T, Nakamoto S, Yokosuka O. Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? World J Virol 2015; 4(3): 178-184
URL http://www.wjgnet.com/2220-3249/full/v4/i3/178.htm
DOI http://dx.doi.org/10.5501/wjv.v4.i3.178
Full Article (PDF) WJV-4-178.pdf
Full Article (Word) WJV-4-178.doc
Manuscript File 18645-Review.doc
Answering Reviewers 18645-Answering reviewers.pdf
Audio Core Tip 18645-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 18645-Conflict-of-interest statement.pdf
Copyright License Agreement 18645-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 18645-Language certificate.pdf
Peer-review Report 18645-Peer-review(s).pdf
Scientific Misconduct Check 18645-Scientific misconduct check.pdf
Scientific Editor Work List 18645-Scientific editor work list.pdf